Home > BIGG > Search result

    Results: 2

    Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

    Johnson, Stuart; Lavergne, Valery; Gonzales-Luna, Luna; Garey, Kevin; Kelly, Ciaran; Wilcox, Mark.
    Clin. infect. dis; 73 (5), 2021
    This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI. This guideline was developed by a multidisciplinary panel representing the Infectious Diseases...
    Clostridium Infections/drug therapy, Fidaxomicin/therapeutic use, Antibodies/therapeutic use, Vancomycin/therapeutic use, Clostridium Infections/diagnosis, Anti-Bacterial Agents/therapeutic use, Clostridium Infections/prevention & control
    Fulltext

    Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

    Ye, ZK; Chen, YL; Chen, K; Zhang, XL; Du, GH; He, B; Li, DK; Liu, YN; Yang, KH; Zhang, YY; Zhai, SD.
    J Antimicrob Chemother; 71 (11), 2016
    BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...
    Anti-Bacterial Agents, Vancomycin, Anti-Bacterial Agents/therapeutic use, Bacterial Infections/drug therapy, Drug Monitoring/methods, Vancomycin/therapeutic use
    Fulltext